1 |
中国医师协会血液科医师分会, 中华医学会血液学分会. 中国多发性骨髓瘤诊治指南(2022年修订)[J]. 中华内科杂志, 2022, 61(5): 480-487.
|
|
Chinese Hematology Association, Chinese Society of Hematology. Guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)[J]. Chinese Journal of Internal Medicine, 2022, 61(5): 480-487.
|
2 |
DINNER S, WITTELES W, WITTELES R, et al. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis[J]. Br J Haematol, 2013, 161(3): 367-372.
|
3 |
BHUTANI D, LENG S Y, LENTZSCH S. Fibril-directed therapies in systemic light chain AL amyloidosis[J]. Clin Lymphoma Myeloma Leuk, 2019, 19(9): 555-559.
|
4 |
BAL S, LANDAU H. AL amyloidosis: untangling new therapies[J]. Hematology Am Soc Hematol Educ Program, 2021, 2021(1): 682-688.
|
5 |
FALK R H, ALEXANDER K M, LIAO R, et al. AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy[J]. J Am Coll Cardiol, 2016, 68(12): 1323-1341.
|
6 |
WECHALEKAR A D, GILLMORE J D, HAWKINS P N. Systemic amyloidosis[J]. Lancet, 2016, 387(10038): 2641-2654.
|
7 |
DUMAS B, YAMEEN H, SAROSIEK S, et al. Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen[J]. Amyloid, 2020, 27(4): 244-249.
|
8 |
SALINARO F, MEIER-EWERT H K, MILLER E J, et al. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis[J]. Eur Heart J Cardiovasc Imaging, 2017, 18(9): 1057-1064.
|
9 |
MACEDO A V S, SCHWARTZMANN P V, DE GUSMÃO B M, et al. Advances in the treatment of cardiac amyloidosis[J]. Curr Treat Options Oncol, 2020, 21(5): 36.
|
10 |
GERTZ M A. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment[J]. Am J Hematol, 2022, 97(6): 818-829.
|
11 |
中国系统性轻链型淀粉样变性协作组, 国家肾脏疾病临床医学研究中心, 国家血液系统疾病临床医学研究中心. 系统性轻链型淀粉样变性诊断和治疗指南(2021年修订)[J]. 中华医学杂志, 2021, 101(22): 1646-1656.
|
|
Chinese Collaborative Group on Systemic Light Chain Amyloidosis, National Clinical Medical Research Center for Kidney Diseases, National Clinical Medical Research Center for Hematology Diseases. Diagnosis and treatment guidelines for systemic light chain amyloidosis (revised in 2021)[J]. Chinese Medical Journal, 2021, 101(22): 1646-1656.
|
12 |
HAHNER S, ROSS R J, ARLT W, et al. Adrenal insufficiency[J]. Nat Rev Dis Primers, 2021, 7(1): 19.
|
13 |
LORIAUX D L, FLESERIU M. Relative adrenal insufficiency[J]. Curr Opin Endocrinol Diabetes Obes, 2009, 16(5): 392-400.
|